What is Ozempic & Mounjaro treatment?
Ozempic (semaglutide) and Mounjaro (tirzepatide) are injectable prescription medications originally developed for the treatment of type 2 diabetes but now widely used for weight management in people with obesity or overweight with related health conditions. Both medications act on hormones in the gut to regulate blood sugar, decrease appetite, slow digestion, and promote a feeling of fullness after eating. While not a surgical option, these treatments have gained attention for their effectiveness in producing clinically significant weight loss without invasive procedures. They are administered once weekly and are often part of a broader program that includes dietary guidance, exercise, and behavioral support.
This treatment helps to:
- Promote steady and sustained weight loss by reducing appetite and food cravings.
- Improve blood sugar control and lower the risk of type 2 diabetes complications.
- Support cardiovascular health by lowering cholesterol and blood pressure.
- Enhance energy levels and metabolic function.
- Provide a non-surgical alternative for individuals not ready or eligible for bariatric surgery.
What to expect after starting Ozempic or Mounjaro?
Patients begin with a low dose that is gradually increased to minimize side effects. Most people notice reduced appetite and smaller portion sizes within the first few weeks. Weight loss is gradual, with many patients achieving meaningful results over 3 to 6 months. These medications are designed for long-term use, and stopping them often results in weight regain.
- Weekly self-administered injections under the skin.
- Mild side effects such as nausea, constipation, or stomach discomfort in early stages.
- Noticeable appetite reduction and improved portion control.
- Weight loss averaging 15–20% of body weight over a year for many patients.
- Ongoing lifestyle support is essential for best results.
